Lettmann Jason - Insider Non-Derivative Transactions at ALX ONCOLOGY HOLDINGS INC (ALXO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 17, 2025, Lettmann Jason's relationship to ALX ONCOLOGY HOLDINGS INC (ALXO) is Director,Officer (CHIEF EXECUTIVE OFFICER), and currently has 305,121 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ALXO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Lettmann Jason - Insider Non-Derivative Transactions of ALXO Common Stock

Lettmann Jason - Insider Non-Derivative Transactions at ALXO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 18, 2025	P -- (Common Stock)	71163	1.08	305121
Sep 17, 2025	P -- (Common Stock)	21070	1.07	233958
Aug 16, 2025	Sell -- (Common Stock)	2382	0.64	212888
Mar 15, 2025	Acquisition -- (Common Stock)	42000	0	212270
Feb 20, 2025	Sell -- (Common Stock)	2159	1.15	170270
Aug 15, 2024	F -- (Common Stock)	2191	2.58	169429
Mar 15, 2024	P -- (Common Stock)	4400	11.31	171620
Feb 15, 2024	Acquisition -- (Common Stock)	60000	0	167220